QR kód

Adverse events following measles, mumps, rubella and varicella virus vaccine live (PROQUAD®) reported to the vaccine adverse event reporting system (VAERS), 2015–2025

Abstract Background PROQUAD®, a quadrivalent live-attenuated vaccine targeting measles, mumps, rubella, and varicella, is widely used in pediatric immunization programs. While clinical trials and post-marketing studies have established its general safety, real-world evidence from large-scale passive...

Celý popis

Uloženo v:
Hlavní autoři: Guojun Liang, Qiong Liu, Yang Song
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-12-01
Edice:Virology Journal
Témata:
PROQUAD
MMRV vaccine
VAERS
Adverse events
Pharmacovigilance analysis
On-line přístup:https://doi.org/10.1186/s12985-025-03022-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky